Lord's Mark Industries Advances Gut Microbiome Analytics and Expands Healthcare Business
Lord's Mark Industries Limited has become India's first company licensed to manufacture an In Vitro Diagnostic Software for its Biomescan Analytics Platform, focusing on gut microbiome analysis to support preventive healthcare. The company projects over 20% revenue growth to Rs 1,550 crore by FY2027, driven by diagnostics, renewable energy, and new medical platforms. It plans to demerge its renewable energy division and expand healthcare services, including CAR-T cell therapy and oncology hospital networks, aiming to enhance patient access and operational efficiency.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (85/100). Lens Score 42/100.
Outlets measured: thetribune, indiatoday. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (85–85/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
indiatoday broke this story on 17 Aug, 08:49 am. Other outlets followed.